ArticleTherapeutic advances in medical oncology2024

A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).

Pierangela Sepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.